跳至主要内容
临床试验/NL-OMON23117
NL-OMON23117尚未招募不适用

The Effect of Rosuvastatin on Immune Activation Markers in treatment-naïve HIV-Positive Patients; A Randomized Placebo-Controlled Trial.

Stichting Research Interne Geneeskunde, OLVG, Amsterdam, the Netherlands0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Adults 18 years of age or older;
  • 2. HIV-1 infection, as documented by a licensed ELISA test kit and confirmed by a Western blot assay;

排除标准

  • 1. Pregnancy or breast feeding;
  • 2. Active drug use or alcohol abuse/dependence, which in the opinion of the investigators will interfere with the patient's ability to participate in the study;

研究者

发起方
Stichting Research Interne Geneeskunde, OLVG, Amsterdam, the Netherlands

相似试验